(Q36068283)

12 August 2017

1 reference

title

In vitro and in vivo effects of HIV protease inhibitors on apoptosis (English)

1 reference

12 August 2017

Badley AD

1

1 reference

12 August 2017

language of work or name

1 reference

1 August 2005

1 reference

Cell Death & Differentiation

12 August 2017

published in

1 reference

12 August 2017

volume

12 Suppl 1

1 reference

12 August 2017

page(s)

924-931

1 reference

Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

HIV-1 protease cleaves actin during acute infection of human T-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Amino-terminal polypeptides of vimentin are responsible for the changes in nuclear architecture associated with human immunodeficiency virus type 1 protease activity in tissue culture cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

In vitro cleavage of eIF4GI but not eIF4GII by HIV-1 protease and its effects on translation in the rabbit reticulocyte lysate system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

HIV-1 protease cleaves eukaryotic initiation factor 4G and inhibits cap-dependent translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Cleavage of eIF4G by HIV-1 protease: effects on translation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Intrinsic and extrinsic pathways signaling during HIV-1 mediated cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Modulation of apoptosis by HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Apoptosis as an HIV strategy to escape immune attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Changes of lymphocyte apoptosis associated with sequential introduction of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Comparative CD4 T-cell responses of reverse transcriptase inhibitor therapy with or without nelfinavir matched for viral exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Reduced levels of CD4 cell spontaneous apoptosis in human immunodeficiency virus-infected patients with discordant response to protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Discordant increases in CD4+ T cells in human immunodeficiency virus-infected patients experiencing virologic treatment failure: role of changes in thymic output and T cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Dynamic correlation of apoptosis and immune activation during treatment of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Immune reconstitution is comparable in antiretroviral-naive subjects after 1 year of successful therapy with a nucleoside reverse-transcriptase inhibitor- or protease inhibitor-containing antiretroviral regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Effects of antiretroviral drugs on human immunodeficiency virus type 1-induced CD4(+) T-cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Antiapoptotic mechanism of HIV protease inhibitors: preventing mitochondrial transmembrane potential loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Mitochondrial membrane hyperpolarization hijacks activated T lymphocytes toward the apoptotic-prone phenotype: homeostatic mechanisms of HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Anti-apoptotic effect of HIV protease inhibitors via direct inhibition of calpain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

The HIV protease inhibitor Indinavir inhibits cell-cycle progression in vitro in lymphocytes of HIV-infected and uninfected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Structure, activation, and biology of calpain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Ritonavir does not inhibit calpain in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Ritonavir inhibition of calcium-activated neutral proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Antiretroviral therapy influences cellular susceptibility to apoptosis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Improved survival in experimental sepsis with an orally administered inhibitor of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

The role of the ubiquitin-proteasome pathway in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Induction of growth arrest and cell death by overexpression of the cyclin-Cdk inhibitor p21 in hamster BHK21 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Antitumorigenic effects of HIV protease inhibitor ritonavir: inhibition of Kaposi sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

A cellular anti-apoptosis protein is cleaved by the HIV-1 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

inferred from DOI database lookup

7 January 2021

based on heuristic

Effect on CD4 T-cell count of replacing protease inhibitors in patients with successful HIV suppression: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

inferred from DOI database lookup

7 January 2021

based on heuristic

Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401580

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.CDD.4401580

1 reference

12 August 2017

1 reference